In the National Institute of Neurological Disorders and Stroke-recombinant tissue plasminogen activator (NINDS-rtPA) stroke trial, the frequency of hypertension and the use of antihypertensive therapy were similar between the rtPA and placebo groups. The gene discussed is PLAT; the disease is Stroke.